Vertebrate DM domain genes encode a novel group of proteins related to the Drosophila doublesex and Caenorhabditis elegans mab-3 transcription factors. It is shown here that the recently identified gene, DMRT3, has a restricted embryonic expression profile that is conserved in chicken and mouse embryos. DMRT3 is expressed primarily in the forebrain, neural tube and nasal placode of both species. In the chicken, DMRT3 is also expressed in newly forming tail somites at early developmental stages and, later, in the Müllerian ducts of the urogenital system. q
Results and discussion
The Drosophila doublesex and Caenorhabditis elegans mab-3 genes encode transcription factors characterized by a conserved zinc finger-like DNA-binding motif, the DM domain. A vertebrate homologue has been identified and named DMRT1 (Doublesex and mab-3-related transcription factor, number 1) (Raymond et al., 1998) . DMRT1 is expressed exclusively in the urogenital system and is implicated in vertebrate testis differentiation (Raymond et al., 1998; Smith et al., 1999; Kettlewell et al., 2000; Guan et al., 2000; Moniot et al., 2000) . Human DMRT1 is part of a DM gene cluster on chromosome 9p, comprising the series DMRT1-DMRT3-DMRT2 (Brunner et al., 2001; Ottolenghi et al., 2002) . These genes share the highly conserved DM domain but have little or no homology outside this region. DMRT2 is expressed primarily in the presomitic mesoderm and in early forming somites of vertebrate embryos (Meng et al., 1999) . It is shown here that DMRT3 also has a conserved, restricted expression pattern in vertebrate (chicken and mouse) embryos. This expression pattern differs from that of DMRT1 and DMRT2. In both chicken and mouse embryos, DMRT3 is expressed primarily in the developing forebrain, neural tube and nasal placodes. In the chicken, DMRT3 is also expressed in early forming somites and presomitic mesoderm, and in the Müllerian ducts.
Embryonic expression of DMRT3 was studied using whole mount in situ hybridization. For both species, embryos were examined during comparable early stages of development. For the chicken, embryos were examined at embryonic day (E)1 (stage 9), E2 (stage 14), E2.5 (stage 16), E3 (stage 18), E4.5 (stage 25) and E7.5 (stage 32). For the mouse, E8.5, 9.5 10.5 and 14.5 embryos were examined. Expression of chicken DMRT3 is shown in Fig. 1 . The earliest identifiable site of expression was within newly forming somites and presomitic mesoderm in stage 9 (E1) embryos (Fig. 1A) . At stage 14 (E2) expression was maintained in the most posterior, early-forming somites, while some weaker expression was apparent in the prospective forebrain region (prosencephalon) (Fig. 1B) . By E2.5 (stage 16) expression had become stronger in the prosencephalon, in the region of the developing telencephalon (Fig.  1C) . Strong expression was also now apparent in the nasal (olfactory) placodes (Fig. 1C) . In the forebrain region, expression was localized along the midline of the developing telencephalon and also along its dorso-caudal walls (Fig.  1D) .
By E3 (stage 18), expression persisted within the cerebral vesicles of the telencephalon, the paired nasal placodes and also along the lateral rims of the maxilla. Weaker expression was apparent in the diencephalon (Fig. 1E) . Sagittal sections through the head region of E3 embryos revealed restricted expression within the neuroepithelium of the telencephalon (dorsal and dorso-caudal walls) (Fig. 1F ). In the facial region, expression was strong within the epithelium of the nasal placodes (Fig. 1G) . Expression in the newly forming (most posterior) somites and presomitic mesoderm continued through stage 18 (E3) (Fig. 1E) . In both the somites and presomitic mesoderm, expression was concentrated at the anterior regions, with expression tapering posteriorly (Fig.  1H) . Several other genes expressed in the newly forming somites show the same pattern of anterior-posterior expression (e.g. Delta and Notch). During somitogenesis, chicken DMRT3 expression was dynamic, being manifest only in the anterior regions of the newly forming somite pair and presomitic mesoderm. Expression was lost as somites aged, and was extinguished altogether by day 4.5 (stage 25) (Fig. 1L) .
DMRT3 also showed restricted expression in the developing neural tube, first evident at E2. By E3 (stage 18), a fine line of expressing cells was evident running the length of the neural tube (Fig. 1I) . These cells were observed bilaterally along the long axis of the neural tube. Longitudinal sections through the neural tube showed a discrete domain of positive cells arranged along the dorso-medial region of the neural tube, but with some cells scattered ventrally (Fig.  1J) . Transverse sections showed that these DMRT3-expressing cells were located within the intermediate or marginal zone of the neural tube (Fig. 1K) .
This restricted expression pattern of DMRT3 in the chicken embryo persisted through subsequent stages. By E4.5 (stage 25), expression was still evident in the telencephalon (although weaker) and in the nasal placodes (Fig.  1L ). The nasal placodes had by this stage given rise to nasal pits, where strong epithelial expression was observed (Fig. 1M) . Bilateral expression persisted along the length of the neural tube, but somitic expression had disappeared (not shown). In older embryos (E7.5; stage 32). sexually dimorphic expression was detected in the Müllerian ducts of the urogenital system, with higher expression in females compared to males (Fig. 1M,N) . No expression was seen in the gonads of either sex (not shown).
A similar pattern of DMRT3 expression was observed in mouse embryos (Fig. 2) . In the mouse, the first detectable site of expression was the cephalic neural fold of E8.5 embryos, in the presumptive forebrain region ( Fig. 2A,B) . In E9.5 and 10.5 embryos, strong expression was seen in the developing forebrain (cerebral vesicles of the telencephalon) and in the nasal placodes (Fig. 2C) . Some expression was also detectable in the post-anal gut and in a small group of cells adjacent to the branchial arches, in the region of the vagal outflow tract (Fig. 2C) . Sagittal sections through the head region showed strong DMRT3 expression within the neuroepithelium of the telencephalon, as in the chicken at comparable stages (Fig. 2D) . Expression in the nasal placodes was localized within the outer epithelial layers (Fig. 2E,F) . As in the chicken, a bilateral line of DMRT3-positive cells was detectable running the length of the neural tube in E9.5 and E10.5 embryos. In longitudinal section, these cells were found along the dorso-medial region of the neural tube (Fig. 2G) , and in transverse sections, within the intermediate (marginal) zone (but not in the ventricular or ependymal layer) (Fig. 2H) .
As in the chicken, these conserved sites of expression persisted in older embryos. Mouse DMRT3 expression persisted in the forebrain and nasal pits in E12-14.5 embryos (not shown), In addition, in E14.5 embryos, some weak expression was detectable in the developing testes of male embryos (but not in ovaries of females) ( Fig. 2I,J ). This contrasts with the expression profile in chicken embryos, in which DMRT3 transcripts were detectable in the Müllerian ducts but not in the gonads. Also in contrast to chicken embryos, no somite expression was observed in the mouse. However, overall, DMRT3 shows a restricted expression profile that is largely conserved in the two species.
Experimental procedures
Specific chicken and mouse DMRT3 DNA fragments were amplified from genomic DNA using degenerate primers. These primers were designed by aligning human and pufferfish DMRT3 with that of a homologous mouse EST (BI904023). The mouse sequence spanned the 3 0 region unique to the DMRTA1-3 subfamily, outside the DM domain (Ottolenghi et al., 2002) . Polymerase chain reaction fragments were cloned into PCRscript vector and sequenced to confirm identity (GenBank numbers pending). These sequences were then used as templates to generate antisense and sense RNA probes. Whole-mount in situ hybridization was carried out on paraformaldehyde-fixed embryos or tissues as described previously (Andrews et al., 1997) . For sectioning, some tissues were left in chromogen solution for an extended period (2 days), cryoprotected in 20% sucrose/PBS, and snap frozen in OCT embedding compound. Fourteen-to eighteen-micrometer frozen sections were taken.
